Thanks alot, 39KP. Very clear

First 27 Last

Share
Profile

Follow
Jerund

146 Posts.

21

15/02/23

14:14

Post #: 66263931
Share

Originally posted by 39KP: ↑

hi Jerund.

i would advise you to look at mozz's post a handful above mine as I don't think I can do much better than that.

I would add that as far as I am aware the data is 'in'. ie it's all been gathered but it's embargoed. ie the company does not have all the data that mozz is referring to. an external party is looking at bio markers / womac etc and aggregating this. I am no expert but i was surprised at how complicated this is and at the time it takes, it takes weeks.

so essentially
data is in
people outside par are analysing it
when they have done their thing they send the summary and underlying to par.
THEN the company decides if it's material and if so they go into a trading halt.
then par spends 1-3 days working out what they legally have to say to the Asx and what they want to say to shareholders. remember they don't necessarily want to say everything as a peer review paper is potentially in the works.
after par has got their ducks in a row they will likely call a shareholder webinar, release the info they want and then the shares can trade.

one last point. the timing around oarsi if it happens is coincidental. there is no way they could have lined this up and I don't believe they are trying to do it on purpose.

if the data is good and they (and mozz) are there, then happy days. but oarsi isn't at all driving any timelines.

hope that helps.

my views only

Expand

Thanks alot, 39KP. Very clear

PAR Price at posting: $1.51 Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

Good habits matters when it comes to finances

Earnings wrap Monday Week 34: A2 Milk, Bluescope, Suncorp's climate woes & more

NOX

Noxopharm aims for autoimmune market with first human trial of SOF-SKN

SMI

Gold intercept of 8.6 g/t continues the positive storyline for Santana at NZ's RAS deposit

PR1

Fourfold skarn increase points the way to viable garnet project, says Pure

First 27 Last

Add PAR (ASX) to my watchlist

(20min delay)
Last 23.0¢		Change 0.000(0.00%)		Mkt cap ! $80.45M

Open	High	Low	Value	Volume
23.5¢	24.0¢	23.0¢	$122.3K	521.4K

Buyers (Bids)

No.	Vol.	Price($)
9	330565	23.0¢

Sellers (Offers)

Price($)	Vol.	No.
23.5¢	50000	1

View Market Depth

No.	Vol.	Price($)
8	325565	0.230
7	100610	0.225
14	252316	0.220
6	73458	0.215
6	140050	0.210

Price($)	Vol.	No.
0.235	50000	1
0.250	29100	2
0.260	20000	2
0.270	13000	2
0.275	10000	1

Last trade - 16.10pm 19/08/2024 (20 minute delay)

PAR (ASX) Chart

Thanks alot, 39KP. Very clear

Good habits matters when it comes to finances

Earnings wrap Monday Week 34: A2 Milk, Bluescope, Suncorp's climate woes & more

Noxopharm aims for autoimmune market with first human trial of SOF-SKN

Gold intercept of 8.6 g/t continues the positive storyline for Santana at NZ's RAS deposit

Fourfold skarn increase points the way to viable garnet project, says Pure

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Thanks alot, 39KP. Very clear

Top Stories

Good habits matters when it comes to finances

Earnings wrap Monday Week 34: A2 Milk, Bluescope, Suncorp's climate woes & more

Noxopharm aims for autoimmune market with first human trial of SOF-SKN

Gold intercept of 8.6 g/t continues the positive storyline for Santana at NZ's RAS deposit

Fourfold skarn increase points the way to viable garnet project, says Pure

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News